EN
HI

SUPRIYA LIFESCIENCE Share price

SUPRIYA

HealthcareMid

696.6

12.85 (-1.81%)
NSE
BSE
Last updated on 16 May, 2025 | 15:52 IST
BUYSELL
Today's High

713.00

Today's Low

691.35

52 Week Low

330.00

52 Week High

842.00

The current prices are delayed, login to your account for live prices

Supriya Lifescience Chart

SUPRIYA LIFESCIENCE Fundamentals

P/E Ratio

32.13

P/B Ratio

5.89

Div. Yield

0.11

Sector P/E

41.98

Sector P/B

4.77

Sec. Div. Yield

0.33

SUPRIYA LIFESCIENCE Resistance and Support

Pivot 702.25

Resistance

First Resistance

719.5

Second Resistance

729.55

Third Resistance

746.8

Support

First Support

692.2

Second Support

674.95

Third Support

664.9

SUPRIYA LIFESCIENCE Futures & Options

Data Not Found

SUPRIYA LIFESCIENCE Shareholding Pattern

    Total Promoters
    Segment
    Percent

    Total Promoters

    68.3%

    Mutual Fund

    0.67%

    Insurance

    2.49%

    Foreign Institutional Investors

    6.52%

    Domestic Institutional Investors

    1.76%

    Retail

    20.26%

    Others

    0%

    Total Promoters
    MAR '24
    68.3%
    JUN '24
    68.3%
    SEP '24
    68.3%
    DEC '24
    68.3%

    SUPRIYA LIFESCIENCE Corporate Actions

    DateAgenda
    2025-03-10Others
    2025-01-24Quarterly Results & Others
    DateEvent TypeAgenda
    2025-03-10Board MeetingOthers
    2025-01-24Board MeetingQuarterly Results & Others

    SUPRIYA LIFESCIENCE News

    Supriya Lifescience opens new API block at Lote Parshuram site in Maharashtra

    Dec 18 2024 05:42:00
    Read More

    About SUPRIYA LIFESCIENCE AboutThe

    NSE : 7390  
    BSE : 543434  
    ISIN : INE07RO01027  

    The Company was incorporated as ‘Supriya Lifescience Limited’ pursuant to a certificate of incorporation dated March 26 2008 issued by the Registrar of Companies Maharashtra at Mumbai (“RoC”) upon the conversion of ‘M/s Supriya Chemicals’ a partnership firm into a public limited company in accordance with the provisions of Part IX of the Companies Act 1956. the Company commenced operations pursuant to a certificate for commencement of business dated April 1 2008 issued by the RoC.Major events and milestones of the Company :2008- Incorporation of the Company upon its conversion from a partnership firm to a public limited company2009- Started production of Ketamine Hydrochloride2010- CEP (Certificate of Sustainability) granted for Chlorphenamine Maleate2011- IDL granted for Chlorphenamine Maleate2013- COFEPRIS and KFDA approval granted2014- USFDA approval granted- IDL granted for Brompheniramine Maleate2015- EUGMP and EDQM approval granted2017- CEP (Certificate of Sustainability) granted for Pheniramine Maleate- Second time USFDA approval granted2018- CEP (Certificate of Sustainability) granted for Brompheniramine Maleate Mepyramine Maleate & Ketamine Hydrochloride2020- Third time USFDA approval2021- CEP (Certificate of Suitability) granted for Pentoxifylline Esketamine Hydrochloride and Salbutamol Sulphate- NMPA approval granted- Health Canada approvaAwards accreditations or recognitions :2009- Certificate of Excellence for outstanding Export Performance in the product group Chemicals Drugs Pharma and Allied Products (MSME) awarded by Federation of Indian Export Organisations2010- Special Recognition National Award for Research and Development awarded by Ministry of Micro Small and Medium Enterprises Government of India2016- Export House for the Year for 2015-16 awarded by Directorate of Industries Government of Maharashtra- Export Achievement for 2015-16 in the product group Basic Chemical Pharmaceutical & Cosmetics Products (MSME) awarded by Directorate of Industries Government of Maharashtra2017- Export House for the Year for 2016-17 awarded by Directorate of Industries Government of Maharashtra- Export Achievement for 2016-17 in the product group Basic Chemical & Pharmaceutical Cosmetics (SSI) awarded by Directorate of Industries Government of Maharashtra2019- Outstanding Export Performance Award for the year 2018-19 for product group API / Bulk Drugs by Pharmaceuticals Export Promotion Council of India

    SUPRIYA LIFESCIENCE Management

    NamePosition
    Mr. Satish Waman Wagh Exe.Chairman & W T D
    Ms. Smita Satish Wagh Whole Time Director
    Ms. Saloni Satish Wagh Whole Time Director
    Ms. Shivani Satish Wagh Whole Time Director
    Mr. Balasahab Gulabrao Sawant Whole Time Director
    Read More

    SUPRIYA LIFESCIENCE FAQs

    SUPRIYA LIFESCIENCE शेयर का खरीद मूल्य 696.6 है। लाइव प्राइस और तत्काल ट्रेडिंग के लिए, आप अपने चॉइस ट्रेडिंग खाते में लॉगिन कर सकते हैं या चॉइस के साथ मुक्त डीमैट खाता खोल सकते हैं।

    SUPRIYA LIFESCIENCE शेयर खरीदने के लिए अपने चॉइस ट्रेडिंग खाते में लॉगिन करें, या चॉइस डीमैट खाता खोल, फिर फंड जोड़ें, कंपनी का नाम खोजें, अपना ऑर्डर टाइप चुनें और ट्रेड प्लेस करें।

    SUPRIYA LIFESCIENCE शेयर का प्राइस-टू-अर्निंग्स (पी/ई) रेशियो 32.13 है। आप सापेक्ष मूल्यांकन के लिए इसकी तुलना सेक्टर के औसत से कर सकते हैं।

    SUPRIYA LIFESCIENCE शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 5.89 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    SUPRIYA LIFESCIENCE शेयर का प्राइस-टू-बुक (पी/बी) रेशियो 4.77 है। यह शेयर के मूल्य की तुलना उसकी बुक वैल्यू से करने में उपयोगी है।

    SUPRIYA LIFESCIENCE का मार्केट कैप 5606.43 CR है। यह कंपनी के आकार की श्रेणी और ट्रेडिंग लिक्विडिटी को दर्शाता है।

    SUPRIYA LIFESCIENCE शेयर का 52 सप्ताह का उच्चतम और न्यूनतम मूल्य 842.00 और 330.00 है। ये मूल्य मूल्य सीमाएं, ट्रेडिंग रेंज, अस्थिरता, संभावित सपोर्ट/रेजिस्टेंस और मूल्य गति को दर्शाते हैं।

    SUPRIYA LIFESCIENCE Share Key Metrics

    Volume
    2.63 L
    Market Cap
    5606.43 CR
    LTQ@LTP
    49@696.60
    ATP
    697.57
    Var Margin
    25.99 %
    Circuit Range
    567.6-851.3
    Delivery %
    36.8 %
    Value
    18.35 CR
    ASM/GSM
    No
    Market Lot
    1